Publisher: Elsevier

Related content
Volume 2, Number 2, 1 April 2002

< previous issue | all issues | next issue >

Favourites:Add to Favourites

Pharmacology
pp. 105-115(11)
Authors: Khakh, B.; Dickenson, T.; Flavahan, N.; Chatterjee, P.; Thiemermann, C.; Newton, R.; Lindsay, M.; Taylor, R.; Futscher, B.; Perretti, M.; Hoffman, P.; Brady, G.; Sharkey, K.; MacNaughton, W.; Furman, B.

Favourites:Add to Favourites

Cardiovascular and renal
pp. 117-118(2)
Authors: Kontinen, V.K.; Carpenter, K.J.

Favourites:Add to Favourites
Favourites:Add to Favourites

Oxygen radicals in cardiovascular-renal disease
pp. 121-125(5)
Author: Schnackenberg, C.G.

Favourites:Add to Favourites

Uric acid and cardiovascular risk
pp. 126-130(5)
Author: Alderman, M.H.

Favourites:Add to Favourites
Favourites:Add to Favourites

B-type natriuretic peptide for the treatment of congestive heart failure
pp. 142-147(6)
Authors: Schreiner, G.F.; Protter, A.A.

Favourites:Add to Favourites

Current treatment and future directions in heart failure
pp. 148-153(6)
Authors: Wells, G.; Little, W.C.

Favourites:Add to Favourites

Disorders of phosphate metabolism in chronic renal disease
pp. 171-176(6)
Author: Edwards, R.M.

Favourites:Add to Favourites

Therapeutic strategies to halt renal fibrosis
pp. 177-181(5)
Authors: Yu, L.; Noble, N.A.; Border, W.A.

Favourites:Add to Favourites

Advances in our understanding of aging: role of the renin-angiotensin system
pp. 189-194(6)
Authors: Ferder, L.F.; Inserra, F.; Basso, N.

Share Content

Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
X
Cookie Policy
ingentaconnect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more